Literature DB >> 35550629

Cohort profile: Bandar Kong prospective study of chronic non-communicable diseases.

Azim Nejatizadeh1, Ebrahim Eftekhar1, Mohammad Shekari1, Hossein Farshidi2, Seyed Hossein Davoodi3, Mehdi Shahmoradi1, Hossein Poustchi4, Amin Ghanbarnejad5, Teymour Aghamolaei5, Hadi Yousefi6, Shideh Rafati5.   

Abstract

Chronic non-communicable diseases (NCDs), are the leading causes of death among adults worldwide. It is projected that half of the NCDs could be avoided by preventing measures. Under the prospective epidemiological research studies in Iran (PERSIAN), we established a prospective population-based cohort study in southern Iran. The present study was designed to observe changing pattern of lifestyle transition over time and investigate the incidence and prevalence of regional modifiable risk factors as well as their associations with major NCDs. At baseline, 4063 participants aged 35-70 years were recruited on Oct, 2016and planned to get re-evaluated every 5 years along with annual follow-up. Data using validated electronic questionnaire comprising 55 questions and 482 items including general, medical and nutrition queries was collected. Blood, hair, nails, urine specimens and anthropometric measurements were taken. The response rate was 99%. In the results; male and female participants were 42.5% and 57.5%, respectively. Of note, 30.4% of women and 16.1% of men were obese. The prevalence of hypertension in men and women was 14.6% and 21%; however, diabetic men and women were 17.4% and 12.4%, respectively. Living in rural areas increased the odds of having hypertension by 1.33 (AOR = 1.33, 95% CI:1-09, 1.61). Noteworthy, logistic regression displayed that aging could predispose individuals to be more overweight, hypertensive and diabetic. The prevalence of multimorbidity of 3 or more NCDs were 8% (No. 326) and 6% (No.240), respectively. Intake of fruits, vegetables and dairy was less than two servings per day in 9.2%, 13% and 58.3% of the participants. Lower cardiovascular diseases and serum level of FBS and higher HDL level in sailors/fishermen compared to other job groups were significant (p-value <0.001). The second annual follow-up was completed and now at the end of the third wave. Findings of the present study signified the high prevalence of behavioral risk factors and their associations with respective NCDs. Subsequently, it is essential to keep track lifestyle variations, the modifiable risk factors and NCDs trends by prospective population-based cohort studies.

Entities:  

Mesh:

Year:  2022        PMID: 35550629      PMCID: PMC9098057          DOI: 10.1371/journal.pone.0265388

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  25 in total

Review 1.  Socioeconomic status and health in the Japanese population.

Authors:  Sadanobu Kagamimori; Alexandru Gaina; Ali Nasermoaddeli
Journal:  Soc Sci Med       Date:  2009-04-16       Impact factor: 4.634

2.  Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran.

Authors:  Akram Pourshams; Hooman Khademi; Akbar Fazeltabar Malekshah; Farhad Islami; Mehdi Nouraei; Ali Reza Sadjadi; Elham Jafari; Nasser Rakhshani; Rasool Salahi; Shahryar Semnani; Farin Kamangar; Christian C Abnet; Bruce Ponder; Nick Day; Sanford M Dawsey; Paolo Boffetta; Reza Malekzadeh
Journal:  Int J Epidemiol       Date:  2009-03-30       Impact factor: 7.196

Review 3.  Noncommunicable diseases.

Authors:  David J Hunter; K Srinath Reddy
Journal:  N Engl J Med       Date:  2013-10-03       Impact factor: 91.245

Review 4.  Poverty and common mental disorders in low and middle income countries: A systematic review.

Authors:  Crick Lund; Alison Breen; Alan J Flisher; Ritsuko Kakuma; Joanne Corrigall; John A Joska; Leslie Swartz; Vikram Patel
Journal:  Soc Sci Med       Date:  2010-05-12       Impact factor: 4.634

5.  Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010.

Authors:  Mohammad Hossein Forouzanfar; Sadaf G Sepanlou; Saeid Shahraz; Daniel Dicker; Paria Naghavi; Farshad Pourmalek; Ali Mokdad; Rafael Lozano; Theo Vos; Mohsen Asadi-Lari; Ali-Akbar Sayyari; Christopher J L Murray; Mohsen Naghavi
Journal:  Arch Iran Med       Date:  2014-05       Impact factor: 1.354

6.  Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010.

Authors:  Mohsen Naghavi; Saeid Shahraz; Sadaf G Sepanlou; Daniel Dicker; Paria Naghavi; Farshad Pourmalek; Ali Mokdad; Rafael Lozano; Theo Vos; Mohsen Asadi-Lari; Ali-Akbar Sayyari; Christopher J L Murray; Mohammad Hossein Forouzanfar
Journal:  Arch Iran Med       Date:  2014-05       Impact factor: 1.354

7.  The relationship between established coronary risk factors and serum copper and zinc concentrations in a large Persian cohort.

Authors:  M Ghayour-Mobarhan; A Shapouri-Moghaddam; M Azimi-Nezhad; H Esmaeili; S M R Parizadeh; M Safarian; S M R Kazemi-Bajestani; G H Khodaei; S J Hosseini; S M J Parizadeh; G A Ferns
Journal:  J Trace Elem Med Biol       Date:  2009-05-06       Impact factor: 3.849

8.  Cohort Profile Update: The Amirkola Health and Ageing Project (AHAP).

Authors:  Ali Bijani; Reza Ghadimi; Ebrahim Mikaniki; Farzan Kheirkhah; Seyyed Ali Mozaffarpur; Mina Motallebnejad; Haleh Esmaili; Fatemeh Majidi; Robert Graham Cumming; Seyed Reza Hosseini
Journal:  Caspian J Intern Med       Date:  2017

9.  Correlation of resting heart rate with anthropometric factors and serum biomarkers in a population-based study: Fasa PERSIAN cohort study.

Authors:  Yashar Goorakani; Massih Sedigh Rahimabadi; Azizallah Dehghan; Maryam Kazemi; Mahsa Rostami Chijan; Mostafa Bijani; Hadi Raeisi Shahraki; Ali Davoodi; Mojtaba Farjam; Reza Homayounfar
Journal:  BMC Cardiovasc Disord       Date:  2020-07-06       Impact factor: 2.298

10.  Is normal body mass index a good indicator of metabolic health in Azar cohort population?

Authors:  Mohammd Hossein Somi; Zeinab Nikniaz; Alireza Ostadrahimi; Amir Taher Eftekhar Sadat; Elnaz Faramarzi
Journal:  J Cardiovasc Thorac Res       Date:  2019-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.